⌕
Wave Life Sciences · WVE · Nasdaq
Tenet 54 · Mixed
Compare
$3.13−0.79%At closeTenet 54 · Mixed
$3.13−0.03 (−0.79%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

Wave Life Sciences (WVE) Stock

Wave Life Sciences (WVE) closed at $3.13 on Nov 13, 2026; its Tenet Score is 54 of 100 against 407 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

Key stats

Previous close
$3.13
Nov 13, 2026
Market cap
$617.3M
share price × the latest quarter's diluted weighted-average share count (vendor)
Dividend yield
0.00%
reinvests all
52-week range
3.00 – 21.73
low → high
Tenet Score
54/100
Mixed · 407 Healthcare peers

Industry: Drugs · see every company filed here →

Wave Life Sciences Inc. scores 54/100. Mixed. Strongest on value and financial health, quality is the soft spot versus 407 Healthcare peers.

Tenet Score · vs sector

n=407
54/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
87
Quality
11
Health
81
Growth
36

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueBQualityFHealthBGrowthDMomentumF
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
1.5×
cap ÷ Sep 30, 2026 book value, Nov 13, 2026 close
P/S
14.4×
price to fiscal 2025 sales
ROE
−80%
TTM through Sep 30, 2026
Operating margin
−504.1%
fiscal 2025, before interest and tax
Net margin
−296.9%
TTM through Sep 30, 2026
Current ratio
8.38
Sep 30, 2026 balance sheet
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 3y
—
This growth figure starts in a period outside the history your plan includes.

The whole report, at a glance · every card is a live peek, click any to open the section

About Wave Life Sciences Inc.

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to redu…

Composite computed Nov 15, 2026 · peer basis: Healthcare (n=407) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 60 US ETFs · top wrappers by weightSee all ETFs holding WVE →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Wave Life Sciences in?

Wave Life Sciences is in the Healthcare sector and the Drugs industry.

What is Wave Life Sciences' Tenet Score?

Wave Life Sciences' Tenet Score is 54 out of 100, ranked against 407 Healthcare peers as of Nov 15, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.